CoChat

Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma

The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.

Abstract

Retinoblastoma clinical observations revealed the role of tumor suppressor genes in human cancer, Knudson's 'two-hit' model of cancer induction. We now demonstrate that loss of both RB1 tumor suppressor gene alleles initiates quiescent RB1(-/-) retinomas with low level genomic instability and high expression of the senescence-associated proteins p16(INK4a) and p130. Although retinomas can remain unchanged throughout life, highly proliferative, clonal and aneuploid retinoblastomas commonly emerge, exhibiting altered gene copy number and expression of oncogenes (MYCN, E2F3, DEK, KIF14 and MDM4) and tumor suppressor genes (CDH11, p75(NTR)) and reduced expression of p16(INK4a) and p130. We suggest that RB1 inactivation in developing retina induces genomic instability, but senescence can block transformation at the stage of retinoma. However, stable retinoma is rarely clinically observed because progressive genomic instability commonly leads to highly proliferative retinoblastoma.

Overview

Integrity signals

Registry

Crossref · 10.1093/hmg/ddn024

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Research works printed but not linked: 2

  1. Radnot, 1977, [Elements of photoreceptors in retinoblastomas (author's transl)], Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 202, 63
  2. Yilmaz, 1998, Twelve novel RB1 gene mutations in patients with hereditary retinoblastoma. Mutations in brief no. 206. Online, Hum. Mutat., 12, 434, 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU16>3.0.CO;2-7 · DOI · Paper page

Cited by

Items 301–349 of 349

Metadata

Authors
Dimaras, H., Khetan, V., Halliday, W., Orlic, M., Prigoda, N. L., Piovesan, B., Marrano, P., Corson, T. W., Eagle, R. C., Squire, J. A., & Gallie, B. L.
Affiliations
  • University of Toronto (CA)
  • Hospital for Sick Children (CA)
  • University Health Network (CA)
  • Princess Margaret Cancer Centre (CA)
  • Wills Eye Hospital (US)
Corresponding author
Gallie, Brenda L.
Venue
Human Molecular Genetics
Published
2008-01-22
Volume
17
Issue
10
Pages
1363-1372
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2122129374
Cited by
351
References
48
Citations by year
2026: 8 · 2025: 19 · 2024: 20 · 2023: 15 · 2022: 24 · 2021: 36 · 2020: 19 · 2019: 19 · 2018: 16 · 2017: 14 · 2016: 12 · 2015: 23 · 2014: 14 · 2013: 20 · 2012: 19
FWCI
24.65
Type
journal article
Language
en
Open access
closed
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Keywords
retinoblastoma, retinoma, genomic instability, cellular senescence, p16INK4a, p130, two-hit model, tumor suppressor, oncogene expression, aneuploidy, MYCN, E2F3, DEK, KIF14, MDM4, cadherin-11, p75 neurotrophin receptor, retinal development, tumor progression
MeSH terms
Adult, Gene Amplification, Homozygote, Humans, Infant, Male, Retinoblastoma, Oncogene Proteins, Tumor Suppressor Protein p53, Retinoblastoma Protein, Disease Progression, Gene Dosage, Proliferating Cell Nuclear Antigen, Ki-67 Antigen, Cyclin-Dependent Kinase Inhibitor p16, Gene Silencing, Tumor Suppressor Proteins, Genomic Instability, Cell Proliferation, Retinoblastoma-Like Protein p130

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.